Loading clinical trials...
Loading clinical trials...
To investigate the efficacy and safety of donepezil in individuals with mild cognitive impairment on measures of cognition, global function and behavior.
Keep your clinical trial research organized — questions to ask, what to expect, and key details.
Lead Sponsor
Eisai Inc.
Collaborators
NCT05877196 · Mild Cognitive Impairment, Alzheimer Disease, and more
NCT06584357 · Mild Cognitive Impairment, Alzheimer's Disease, and more
NCT03574207 · Mild Cognitive Impairment, Memory Loss
NCT05594017 · Epilepsy, Seizures, and more
NCT04701177 · Presymptomatic Disease, Mild Cognitive Impairment, and more
Albaster, Alabama
Mesa, Arizona
Peoria, Arizona
Use Clareo to keep notes, questions, trial details, and next steps organized before and after appointments.
Start free trial →Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions